文献速递腹部泌尿生殖MR

重新审视壁外血管侵犯(EMVI):详细分析EMVI各项特征及其作为直肠癌新辅助治疗反应预测影像生物标志物的作用

Extramural venous invasion (EMVI) revisited: a detailed analysis of various characteristics of EMVI and their role as a predictive imaging biomarker in the neoadjuvant treatment response in rectal cancer.
PubMed 文献 · Abdom Radiol (NY) · 2022-03-24

纳入57例局部进展期直肠腺癌患者,在新辅助治疗前后行MRI,由两名腹部放射科医师重点评估EMVI。完全/近完全缓解者的MR-EMVI数量(均值1.45)和直径(均值1.8 mm)小于部分缓解者(2.54和3.3 mm,p<0.005)。MRI检测残留EMVI敏感度高、特异度中等,1例经弹性蛋白染色改变了最终判断。

要点

  • 完全/近完全缓解者MR-EMVI数量均值1.45、直径均值1.8 mm,均小于部分缓解者的2.54和3.3 mm(p<0.005)。
  • MRI检测残留EMVI敏感度高、特异度中等。
  • 5例残留MR-EMVI阳性者病理见癌沿血管束呈蛇行性血管周围播散,虽未见于血管腔内。

核心结论

  • MR-EMVI的存在、大小和数量可能具有临床意义,这些参数也应纳入MRI评估和治疗反应预后判断。
  • 从病理角度看,肿瘤沿大血管生长即使未明确见于血管腔内,也可能反映EMVI。

研究设计与样本

  • 研究类型为影像-病理对照分析,纳入57例局部进展期直肠腺癌患者。
  • 患者在新辅助治疗前后均行MRI扫描,由两名腹部放射科医师评估图像,重点观察EMVI。
  • 计算MRI检测残留EMVI的敏感度和特异度,并分析MR-EMVI数量、大小及主要静脉受累与治疗反应的关系。
  • 对影像与病理不一致的病例行弹性蛋白染色,并由多学科团队现场重新评估图像和切片。

关键影像表现/征象

  • 初始评估时17例(29.8%)为MR-EMVI阴性,40例(70.2%)为MR-EMVI阳性。
  • 5例残留MR-EMVI阳性者病理见癌沿血管束呈蛇行性血管周围播散,虽未见于血管腔内。

诊断标准与关键数值

  • 完全/近完全缓解者MR-EMVI数量均值1.45、直径均值1.8 mm,部分缓解者分别为2.54和3.3 mm(p<0.005)。
  • MRI检测残留EMVI的敏感度高、特异度中等。
  • 1例患者经弹性蛋白染色改变了最终判断。

临床应用与阅片要点

  • MRI评估直肠癌新辅助治疗反应时,除EMVI存在与否外,还应记录EMVI的数量和大小。
  • 肿瘤沿大血管生长但未见血管腔内侵犯时,也可能提示EMVI,需结合病理及弹性蛋白染色综合判断。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To assess whether size, diameter, and large vein involvement of MR-detected extramural venous invasion (MR-EMVI) have an impact on neoadjuvant therapy response in rectal adenocarcinoma.

METHODS: 57 patients with locally advanced rectal adenocarcinoma scanned with MRI before and after neoadjuvant therapy were included. Two abdominal radiologists evaluated the images with special emphasis on EMVI, on initial staging and after neoadjuvant treatment. The sensitivity and specificity of MRI for detection of rest EMVI were determined. The association of various MR-EMVI characteristics including number, size, and main vein involvement with treatment response was investigated. In subjects with discordance of radiology and pathology, elastin stain was performed, and images and slides were re-evaluated on site with a multidisciplinary approach.

RESULTS: At initial evaluation, 17 patients were MR-EMVI negative (29.8%) and 40 were MR-EMVI positive (70.2%). Complete/near-complete responders had less number (mean 1.45) and smaller diameter of MR-EMVI (mean 1.8 mm), when compared with partial responders (2.54 and 3.3 mm; p < 0.005). The sensitivity of MRI for rest EMVI detection was high, specificity was moderate, and in one patient elastin stain changed the final decision. In five patients with rest MR-EMVI positivity, carcinoma histopathologically had a distinctive serpiginous perivascular spread, growing along the track of vascular bundle, although it did not appear in intravascular spaces.

CONCLUSION: This study demonstrates that not only the presence, but also size and number of EMVI that may be significant clinically and thus these parameters also ought to be incorporated to the MRI evaluation and prognostication of treatment response. From pathology perspective, tumors growing alongside major vessels may also reflect EMVI even if they are not demonstrably "intravascular."

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Altinmakas, Dogan, Taskin, et al. Extramural venous invasion (EMVI) revisited: a detailed analysis of various characteristics of EMVI and their role as a predictive imaging biomarker in the neoadjuvant treatment response in rectal cancer. Abdom Radiol (NY). 2022. PMID: 35332398. doi:10.1007/s00261-022-03495-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。